4[1]Rischitelli DG,Sean H,Karbowlcz,et al.Satety and efficacy of controlled-release oxycodone:a systematic literature review.Pharmacotherapy,2002,22(7):898-904.
5[2]Roth SH,Ffleischmann RM,Burch FX,et al.Around the clock,controlled-relaease oxycodone therapy for osteoarthritis related pain;placebo-controlled trial and long-term evaluation.Arch Intern Med,2000,160(6):853-860.
6[3]Jamison RN,Raymond SA,Slawsby EA.Opioid therapy for chronic noncancer back pain:A randomized prospective study.Spine,1998,23(23):2591-2600.
8[5]Ackerman SJ,Mordin M.Patient-reported utilization pattems of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain.J Manag Care Pharm,2003,9(3):223-231.
8Yu S,Wang XS,Cheng Y,et al.Special aspects of cancer pain management in a Chinese general hospital[J].Eur J Pain,2001,5Suppl A:15-20.
9Nielsen C K,Ross FB,Lotfipour S,et al.Oxycodone and morphine have distinctly different pharmacological profiles:radioligand binding and behavioural studies in two rat models of neuropathic pain[J].Pain,2007,132(3):289-300.
